We are pleased to announce our research papers have been published in scientific journals.

Yasuda K, Shimodan S, Maehara N, Hirota A, Iijima R, Nishijima A, Mori H, Toyama R, Ito A, Yoshikawa Y, Arai S, Miyazaki T. AIM/CD5L ameliorates autoimmune arthritis by promoting removal of inflammatory DAMPs at the lesions. J Autoimmun. 2023, 142, 103149.

Research Fellow Kai Kudo* presented at the Research Meeting of Japan Health Foundation

• Date: November 11, 2023 (Saturday)
• Venue: Kyoto Tower Hotel
• Title: Discovery of a Novel Fatty Acid Desaturase Triggered by EBV Infection: Paving the Way for Medical Development

※Affiliated with Tokai University School of Medicine at the time of application and employment for the grant project

Research Fellow Kai Kudo* was awarded the "Encouragement Award" by the Japan Society of Clinical Chemistry (JSCC) in 2023.
*At the time of application, he was affiliated with Tokai University School of Medicine.

We are pleased to announce our research papers have been published in scientific journals.

Okanoue T, Yamaguchi K, Shima T, Mitsumoto Y, Katayama T, Okuda K, Mizuno M, Seko Y, Moriguchi M, Itoh Y, Miyazaki T. Artificial intelligence/neural network system that accurately diagnoses hepatocellular carcinoma in nonalcoholic steatohepatitis.
Hepatol Res. 2023, Online ahead of print.

Nemoto H, Honjo M, Arai S, Miyazaki T, Aihara M. Apoptosis inhibitor of macrophages/CD5L enhances phagocytosis in the trabecular meshwork cells and regulates ocular hypertension.
J Cell Physiol. 2023, Online ahead of print.

Director Miyazaki to Present at "Mirai Igaku Kenkyu Kai(Future Medicine Research Society^※)."

45th Mirai Igaku Kenkyu Kai Conference "think outside the box"
Special Lecture

• Date: July 8, 2023 (Saturday) 13:00-17:50
• Venue: Nihonbashi Life Science Hub 8F
• Presentation Title: The Day Cats Live to 30 and Human Dialysis Becomes Unnecessary: From the Discovery of AIM to Drug Development

※Official English translation is not available

Director Miyazaki Invited to Speak at the Japanese Society for Dialysis Therapy.

68th Annual Meeting of the Japanese Society for Dialysis Therapy
Special Lecture

• Date: June 18, 2023 (Sunday) 10:40-11:40
• Venue: Kobe Convention Center
• Title: Significance of Blood Protein AIM in the Diagnosis and Treatment of End-Stage Chronic Kidney Disease

Director Miyazaki and Vice Director Arai will give an oral presentation at the 3rd RESOLUTION DAYS.

3rd RESOLUTION DAYS

• Date: April 27, 2023
• Venue: Hôtel Mercure Besancon Parc Micaud (Besancon, France)
• Title: Facilitation of disease repair through phagocytic removal of different inflammatory elements by AIM/CD5L

At the 56th Annual Meeting of the Japan Society for Clinical Renal Transplantation, Director Toru Miyazaki delivered a special lecture.

Event Details

• Date: February 12, 2023 (Sunday)
• Venue: The Okura Tokyo
• Topic: Diagnostic and Therapeutic Significance of AIM in End-stage Kidney Disease (ESKD)

Vice Director Arai^※ will participate as an organizer and speaker in a symposium at the 100th Anniversary Annual Meeting of the Physiological Society of Japan.

The 100th Anniversary Annual Meeting of the Physiological Society of Japan

• Presentation Date: March 15, 2023 (Wednesday)
• Venue: Kyoto International Conference Center
• Symposium Theme: Understanding Chronic Inflammatory Diseases from a Metabolic Perspective
• Presentation Title: Therapeutic and Diagnostic Impacts of AIM on Refractory Chronic Diseases

※Affiliated with the Graduate School of Medicine, the University of Tokyo

Vice Director Arai^※ Presented as Symposium Chair and Speaker at the 51st Annual Meeting of the Japanese Society for Immunology.

51st Annual Meeting of the Japanese Society for Immunology

• Presentation Date: December 7, 2022 (Wednesday)
• Venue: Kumamoto Castle Hall
• Symposium Theme: Introduction to innovative science for "resolution of inflammation"

※Presenting as a member of the University of Tokyo, Graduate School of Medicine